People can delay a couch, a vacation, or a phone upgrade. They are much less casual about the dog’s dinner, the cat’s meds, or the vet visit they have been pretending to schedule for two weeks. That is what makes the pet space so interesting. It blends consumer behavior with healthcare-like stickiness.
Insider Access (Sponsored)
Bloomberg is calling Elon Musk's upcoming SpaceX IPO "the biggest listing of ALL TIME."
But here's the thing - most investors will be locked out until AFTER it goes public.
Not you.
I've found a 'backdoor' that lets everyday Americans grab a pre-IPO stake in SpaceX right now.
Click Here for the FREE "SpaceX" Ticker
Theme: Pets and Animal Health: A Sticky Demand With Better Mix
Pet spending works because much of it is habitual, emotional, and annoyingly non-optional. Food is recurring. Preventive care is recurring. Diagnostics are recurring. Even when consumers get pickier, they often trade around the edges instead of abandoning the category altogether. That creates a durable setup for the right operators.
Here is the chain reaction:
Pet ownership stays high → recurring spending stays embedded
Recurring spending stays embedded → food and care volumes remain durable
Durable demand → premium products and health services hold share
Premium products and services hold share → margins can improve through mix
Better mix and scale → cash flow gets cleaner
This theme matters because it is not one business. It is several.
You have pet health names that benefit when clinics run more diagnostics and prescribe more treatments. You have food and fresh-food names that benefit when owners keep premiumizing. And you have retail and e-commerce players that benefit when repeat orders and convenience matter more than wandering the aisle debating between chicken recipe and salmon recipe like it is a life event.
The animal health side still looks especially interesting. Zoetis guided 2026 revenue to $9.825 billion to $10.025 billion, with adjusted EPS of $7.00 to $7.10, while IDEXX guided 2026 revenue to $4.632 billion to $4.720 billion and EPS to $14.29 to $14.80. Those are not numbers you put up if the pet category is quietly falling through the floor.
At the same time, this is no longer a free-money theme. Vet visit trends have become more scrutinized, competition is real, and retail pet operators still have to prove they can drive demand without turning promotions into a personality. Reuters noted that IDEXX’s 2026 guidance came in above expectations, but investors were still watching clinic traffic carefully.
What we want to see to stay bullish
Stable pet food and pet health demand
Strong recurring diagnostics or prescription trends
Margin improvement from mix, not just cost cuts
Clean execution in retail and e-commerce
Evidence premiumization is slowing less than feared
What can ruin the party
If consumers start trading down harder, fresh food, premium nutrition, or discretionary accessories can soften. Vet visit trends can also wobble if owners delay care. Retail pet operators remain vulnerable to execution mistakes. This is a resilient category, not an invincible one.
Zoetis (ZTS)
What it does: Animal health giant across companion-animal and livestock medicines, vaccines, and diagnostics.
Why it fits: Zoetis is the closest thing this theme has to a category anchor. It reported full-year 2025 adjusted diluted EPS of $6.41 and guided 2026 revenue to $9.825 billion to $10.025 billion, with adjusted EPS of $7.00 to $7.10.
What could go right:
Companion-animal demand stabilizes and improves
New product mix supports margins
Livestock strength adds a second growth engine
Cash flow and pricing discipline stay strong
What to watch next: Companion-animal trends in the U.S., where investors have been especially sensitive, plus whether management keeps showing enough growth to quiet the competition fears that hung over the stock after fourth-quarter results.
Risk: Zoetis is high quality, but it is not immune to slowdown concerns in companion-animal spending.
IDEXX Laboratories (IDXX)
What it does: Veterinary diagnostics and software, tied closely to clinic visits and testing intensity.
Why it fits: IDEXX sits in a powerful part of the pet ecosystem because diagnostics are embedded in care quality. The company guided 2026 revenue to $4.632 billion to $4.720 billion and EPS to $14.29 to $14.80, with expected organic revenue growth of 7 percent to 9 percent.
What could go right:
Diagnostics recurring revenue remains durable
New placements and test utilization keep building
Margin improvement continues as scale rises
Software and workflow tools deepen clinic stickiness
What to watch next: Vet clinic traffic, inVue Dx placements, and companion animal diagnostics recurring revenue. Investors were upbeat on the business after fourth-quarter results, but still cautious on visit trends.
Risk: If clinic visits soften more than expected, sentiment can turn quickly even if the franchise stays strong.
Free Live Event (Sponsored)
What if one trade placed at 3:30 p.m. could set you up for a potentially massive overnight gain?
Bryan’s Stock Flipping strategy is designed to buy strong stocks on weak days, then flip them the next morning for gains targeting up to 667% overnight.
During this free live event on Wednesday, March 18 at 2 p.m. ET, he’ll reveal the full strategy, the stocks to watch, and the criteria behind the setup.
He’ll also show the 10+ year track record and explain the 87% statistical edge behind the method.
[Sign up here to reserve your spot]
Chewy (CHWY)
What it does: E-commerce platform for pet food, supplies, pharmacy, and increasingly broader pet health services.
Why it fits: Chewy remains the convenience name in the theme. The company has not yet reported fiscal 2025 results as of March 12, 2026, but it scheduled that report for March 25, 2026, after previously posting fiscal 2024 results that beat the high end of its guidance and were supported by active customer growth and Autoship loyalty.
What could go right:
Autoship keeps acting like a sticky recurring engine
Pharmacy and health services broaden the story
Better mix supports margins
Active customer growth stabilizes or improves
What to watch next: The upcoming March 25 earnings call, especially active customer trends, Autoship mix, and first-quarter guidance follow-through.
Risk: Since fresh fiscal 2025 results are not out yet, investors are leaning on expectations. That can make the stock jumpy.
Freshpet (FRPT)
What it does: Fresh refrigerated pet food brand positioned around premium nutrition.
Why it fits: Freshpet is the premiumization bet in the basket. It reported fourth-quarter and full-year 2025 results on February 23, 2026, and guided 2026 net sales growth to 7 percent to 10 percent, with adjusted EBITDA of $205 million to $215 million.
What could go right:
Fresh food demand remains resilient
Margin structure improves as scale and manufacturing efficiency get better
Brand strength supports pricing and mix
Distribution expansion still adds runway
What to watch next: Whether growth stays healthy without the company having to overspend to get it, plus whether margin improvement continues cleanly. The market likes Freshpet most when it looks like a premium brand that is finally acting like an adult on profitability.
Risk: Premium categories are usually the first place investors worry when the consumer gets cautious.
Free Report (Sponsored)
From thousands of stocks, only five stood out as having the best chance to gain +100% or more in the months ahead.
A newly released 5 Stocks Set to Double special report reveals all five tickers — free for a limited time.
While future results can’t be guaranteed, previous editions of this report delivered gains of +175%, +498%, and even +673%¹.
The newest picks could follow a similar path.
This free opportunity expires at MIDNIGHT TONIGHT.
Get the free report here
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
Petco Health and Wellness (WOOF)
What it does: Pet retail, supplies, grooming, and veterinary services.
Why it fits: Petco is clearly the messiest name in the basket, but sometimes that is useful in a thematic rundown. The company reported fourth-quarter and full-year 2025 results on March 12, 2026, with fourth-quarter net sales down 2.4 percent and comparable sales down 1.6 percent, which tells you the category is resilient but not effortless.
What could go right:
Better store execution and tighter inventory improve profitability
Services and vet offerings support traffic quality
Cost and debt actions improve the financial picture
Any stabilization in comp trends changes sentiment fast
What to watch next: Margin progress, same-store sales, and whether the company can make services matter more relative to basic retail. Petco recently refinanced debt, which helps reduce one obvious pressure point.
Risk: High. This is the turnaround speculation slot, not the clean compounder.
Want to make sure you never miss a stock recommendation?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell. Email’s great. Texts are faster.
The pet category is no longer a momentum free-for-all, and that is actually what makes it more interesting. The easy money is gone, but the recurring demand is still there. Food, diagnostics, meds, and care remain sticky, and the better operators can still turn that into reliable growth and cleaner cash flow.
Watch clinic traffic, premium food demand, and whether retail names can stabilize without bribing customers with constant promotions. If those signals hold, this is still one of the better resilience themes on the board.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
